Cancer Vaccine Cuts Melanoma Recurrence by 49%

Moderna Shares Surge Nearly 177% After Personalised Cancer Vaccine Succeeds in Phase 3 Trial Moderna shares surged nearly 177% on Wednesday after the US biotech company and Merck reported positive results from a large late-stage trial of…
Read More...